Breaking News Instant updates and real-time market news.

UBSFY

Ubisoft

$0.00

(0.00%)

, SNE

Sony

$47.78

-0.225 (-0.47%)

18:56
06/03/19
06/03
18:56
06/03/19
18:56

Ubisoft's Remy says doesn't want 'Rainbow Six Siege' sequel, Daily Star says

Alexandre Remy, brand director of Ubisoft's (UBSFY) shooting game "Rainbow Six Siege," said that he wants the game to appear on the next generation of PlayStation (SNE) and Xbox (MSFT) consoles, but that he's not interested in making a sequel to the popular shooter, the Daily Star's Jim Hargreaves reports. "We don't want a sequel whatsoever," Remy said, adding that he couldn't give any specifics about the game's presence on future consoles but that he and the team want the game to make that generational leap, according to the Daily Star. "The reason behind this is we don't want to segregate our community between the different platforms," he added. "In an ideal world tomorrow, we'd love players from every platform to be able to play together. We are approaching next-gen with the same spirit." Reference Link

UBSFY

Ubisoft

$0.00

(0.00%)

SNE

Sony

$47.78

-0.225 (-0.47%)

MSFT

Microsoft

$119.93

-3.66 (-2.96%)

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 10

    Jun

  • 11

    Jun

  • 13

    Jun

  • 23

    Jun

  • 10

    Jul

  • 06

    Aug

UBSFY Ubisoft
$0.00

(0.00%)

01/11/19
01/11/19
INITIATION

Fly Intel: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Activision Blizzard (ATVI), Take-Two (TTWO), Electronic Arts (EA), Glu Mobile (GLUU) were initiated with an Overweight at Stephens, while the analyst also initiated Zynga (ZNGA) and Ubisoft (UBSFY) with an Equal Weight. 2. Domino's Pizza (DPZ) initiated with an Outperform at Cowen. 3. Okta (OKTA) and Zscaler (SZ) initiated with an Overweight at Piper Jaffray. 4. Lennar (LEN), D.R. Horton (DHI) and NVR (NVR) initiated with a Buy and KB Home (KBH), PulteGroup (PHM), Hovnanian (HOV) and Toll Brothers (TOL) initiated with a Neutral at Buckingham. 5. VMware (VMW) reinstated with a Neutral at Goldman SachsThis list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
05/15/19
GSCO
05/15/19
NO CHANGE
GSCO
Goldman says report of Epic store unlock in China positive for Take-Two, Ubisoft
After a report citing Chinese news site Techweb claimed that the Epic games store has been unlocked in China, Goldman Sachs analyst Michael Ng said he views the news as positive for video game publishers, notably Take-Two (TTWO) and Ubisoft (UBSFY) given the launches of Borderlands 3 and The Outer Worlds by the former and The Division 2 and Ghost Recon Breakpoint for the latter. Ng has a Buy rating on Take-Two and a Neutral rating on Ubisoft.
01/30/19
GSCO
01/30/19
INITIATION
GSCO
Neutral
Ubisoft initiated with a Neutral at Goldman Sachs
Goldman Sachs analyst Michael Ng started Ubisoft with a Neutral rating and EUR 81 price target. Ubisoft, among its video game peers, generates a smaller share of bookings from digital, in-game spending, and mobile, resulting in lower EBIT margins, Ng tells investors in a research note. Further, he believes the company's valuation is high relative to peers and that its near-term growth opportunities are well understood.
01/17/19
JEFF
01/17/19
DOWNGRADE
JEFF
Hold
Ubisoft downgraded to Hold from Buy at Jefferies
Jefferies analyst Timothy O'Shea downgraded Ubisoft to Hold.
SNE Sony
$47.78

-0.225 (-0.47%)

04/23/19
04/23/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Qualcomm (QCOM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst James Faucette citing his view that the market has "not yet fully appreciated" the impact of the company's settlement with Apple (AAPL), which he thinks not only increases earnings substantially while also expanding the freedom with which Qualcomm can pursue new opportunities. 2. Kimberly-Clark (KMB) upgraded to Buy from Hold at Argus and to Outperform from Neutral at Macquarie. 3. Sanderson Farms (SAFM) upgraded to Neutral from Sell at Goldman Sachs with analyst Adam Samuelson saying African swine fever is upending the protein markets, Samuelson tells investors in a research note. 4. Visteon (VC) upgraded to Outperform from Neutral at Baird while Veoneer (VNE) was upgraded to Neutral from Underperform. 5. Sony (SNE) upgraded to Outperform from Neutral at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/24/19
04/24/19
INITIATION
Target $18

Buy
Chicken Soup for the Soul initiated with a Buy at Maxim
As previously reported, Maxim analyst Allen Klee initiated Chicken Soup for the Soul (CSSE) with a Buy rating and a price target of $18. The analyst expects the company's Crackle Plus online streaming joint venture with Sony (SNE) to double the company's revenues in 2019, making it "one of the largest players in the attractive advertising video-on-demand market." Klee also cites Chicken Soup for the Soul's "strong brands, accretive acquisitions, low risk TV production, and revenue streams from production/distribution/advertising", positioning the company for longer term growth. The analyst further cites the attractive valuation for the shares at 12-times his expected 2019 adjusted EBITDA.
05/14/19
CHLM
05/14/19
NO CHANGE
Target $14
CHLM
Buy
Immersion can get back to profitability in 2020, says Craig-Hallum
Craig-Hallum analyst Anthony Stoss raised his price target for Immersion (IMMR) to $14 from $12 after the company signed both Samsung (SSNLF) and Sony (SNE), and raised 2019 guide. The analyst thinks the company can get back to profitability in 2020 based on new deal signings and cost cuts. He reiterates a Buy rating on Immersion shares.
05/17/19
BARD
05/17/19
NO CHANGE
BARD
Sony, Microsoft JV a 'surprsing turn' in 'battle for living room,' says Baird
Baird analyst Colin Sebastian said he views the joint venture pact between competitors Microsoft (MSFT) and Sony (SNE) on cloud-based gaming services as both "surprising" and a validation of the emerging market for streaming. The two companies clearly view video games as strategically important enough to put aside their intense competition and see Google (GOOGL) as a legitimate competitor and the Stadia streaming platform as a credible threat, said Sebastian, who added that he does not believe this means Sony and Microsoft will forego their separate console hardware platforms. He also believes that video game developers and publishers should benefit from the intensifying battle among platform companies for share of the game market and the "living room audience." Publicly traded game makers include Activision Blizzard (ATVI), Electronic Arts (EA) and Take-Two (TTWO).
MSFT Microsoft
$119.93

-3.66 (-2.96%)

05/22/19
OPCO
05/22/19
NO CHANGE
Target $145
OPCO
Outperform
Microsoft restructured itself around intelligent edge cloud, says Oppenheimer
After attending the Microsoft Build Developer Conference, Oppenheimer analyst Timothy Horan notes it became obvious that the company has totally restructured itself around the intelligent edge cloud. Microsoft sees Azure as a base layer that customers use to run their applications on top of but also as a building block for its services up the software "stack" through dozens of new PaaS and SaaS offerings, he contends. The analyst adds that by running on Azure, Microsoft applications become cheaper to operate, easier to innovate, and integrate the services. He reiterates an Outperform rating and $145 price target on the shares.
05/22/19
FANA
05/22/19
NO CHANGE
Target $47
FANA
Strong Buy
Meetings with Pluralsight highlight GitPrime opportunity, says First Analysis
First Analysis analyst Corey Greendale kept his Strong Buy rating and $47 price target on Pluralsight (PS) after meeting with its management, saying the discussion highlighted opportunities around the "market expansion potential" from its GitPrime acquisition. The analyst believes that the company can generate strong free cash flow and produce organic revenue growth of over 30% as it continues to improve its sales and marketing efficiency. Greendale adds that Pluralsight managment also highlighted the "efficiency potential" of its Microsoft (MSFT) partnership.
05/29/19
DADA
05/29/19
INITIATION
Target $27
DADA
Neutral
Slack Technologies initiated with a Neutral at DA Davidson
DA Davidson analyst Rishi Jaluria initiated Slack Technologies (WORK) with a Neutral rating and a price target of $27. The analyst says he is positive on the company's "near-ubiquitous nature", large market opportunity, rapid growth, and secular tailwinds of the industry, but believes that the stock is is "fully valued" at 15-times enterprise value to his expected FY20 revenue, which is above the 12-times multiple of Slack's peer group average. Jaluria adds that with no lock up period and competition from Microsoft (MSFT) Teams, trading in Slack shares can be volatile.
05/31/19
MSCO
05/31/19
NO CHANGE
Target $145
MSCO
Overweight
Microsoft unique as share gainer in old and new 'stacks,' says Morgan Stanley
Morgan Stanley analyst Keith Weiss said Microsoft is in the unique position of being the top share gainer in the "Old Stack" software technologies, such as relational databases, while also being well positioned for several rapidly growing "New Stack" software areas, such as NoSQL databases, PaaS and Developer Planning & Automation Tools. Weiss, who reiterates an Overweight rating and $145 price target on Microsoft shares, contends that the company might be "one of the few vendors with significant Old Stack share to effectively transition for the software development future."

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

16:29
10/13/19
10/13
16:29
10/13/19
16:29
Periodicals
Google bars high-interest consumer loan services from app store, WSJ reports »

Google has barred…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

16:28
10/13/19
10/13
16:28
10/13/19
16:28
General news
Trump working with Congress on 'powerful' Turkey sanctions »

President Trump tweeted…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$169.06

1.255 (0.75%)

16:23
10/13/19
10/13
16:23
10/13/19
16:23
Hot Stocks
Allergan, Molecular Partners present data from Phase 3 Abicipar pegol studies »

Allergan and Molecular…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LYFT

Lyft

$39.49

1.8 (4.78%)

, UBER

Uber

$30.09

1.19 (4.12%)

16:04
10/13/19
10/13
16:04
10/13/19
16:04
Periodicals
Lyft sues NYC over cruising time caps, Reuters reports »

Following its rival…

LYFT

Lyft

$39.49

1.8 (4.78%)

UBER

Uber

$30.09

1.19 (4.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 04

    Nov

  • 07

    Nov

  • 19

    Nov

GM

General Motors

$35.57

0.9 (2.60%)

15:59
10/13/19
10/13
15:59
10/13/19
15:59
Periodicals
UAW boosting strike pay as General Motor walkout continues, Reuters says »

The United Auto Workers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

MRK

Merck

$84.31

0.6 (0.72%)

, JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

15:49
10/13/19
10/13
15:49
10/13/19
15:49
Periodicals
Congo to start using Johnson & Johnson Ebola vaccine next month, Reuters says »

Health authorities in…

MRK

Merck

$84.31

0.6 (0.72%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 24

    Jan

  • 24

    Jan

  • 14

    Mar

HMTV

Hemisphere Media

$11.70

0.05 (0.43%)

15:48
10/13/19
10/13
15:48
10/13/19
15:48
Initiation
Hemisphere Media initiated  »

Hemisphere Media…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$36.11

0.31 (0.87%)

15:37
10/13/19
10/13
15:37
10/13/19
15:37
Hot Stocks
Pfizer presents Phase 3 data for Abrocitinib in moderate to severe AD »

Pfizer announced complete…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

CNCE

Concert Pharmaceuticals

$5.85

(0.00%)

15:29
10/13/19
10/13
15:29
10/13/19
15:29
Hot Stocks
Concert Pharmaceuticals presents Phase 2 data in Alopecia Areata »

Concert Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INCY

Incyte

$76.14

0.38 (0.50%)

15:23
10/13/19
10/13
15:23
10/13/19
15:23
Hot Stocks
Incyte announces 52-week results from Phase 2 study of Ruxolitinib cream »

Incyte announced 52-week…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

LLY

Eli Lilly

$108.37

1.54 (1.44%)

14:15
10/13/19
10/13
14:15
10/13/19
14:15
Hot Stocks
Eli Lilly says Taltz met co-primary endpoints in Phase 3 plaque psoriasis study »

Eli Lilly announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

PCG

PG&E

$8.08

0.3 (3.86%)

07:46
10/13/19
10/13
07:46
10/13/19
07:46
Hot Stocks
PG&E says all customers impacted by safety shutoffs now have power »

Pacific Gas and Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Nov

  • 10

    Nov

  • 12

    Nov

  • 07

    Jan

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

, VIR

Vir Biotechnology

$14.06

(0.00%)

07:18
10/13/19
10/13
07:18
10/13/19
07:18
On The Fly
Opening Day: BioNTech raises $150M in smaller than expected IPO »

BioNTech (BNTX) raised…

BNTX

BioNTech

$13.50

-0.85 (-5.92%)

VIR

Vir Biotechnology

$14.06

(0.00%)

HBT

HBT Financial

$15.56

(0.00%)

SFTBF

SoftBank

$0.00

(0.00%)

SFTBY

SoftBank

$0.00

(0.00%)

WE

We Company

$0.00

(0.00%)

KRAT

Karat Packaging

$0.00

(0.00%)

POST

Post Holdings

$101.19

1.94 (1.95%)

IPHA

Innate Pharma

$0.00

(0.00%)

BRBR

BellRing Brands

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 17

    Oct

  • 17

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/13/19
10/13
04:55
10/13/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

AMBA

Ambarella

$53.62

1.25 (2.39%)

, ON

ON Semiconductor

$18.74

0.67 (3.71%)

09:31
10/12/19
10/12
09:31
10/12/19
09:31
On The Fly
Week in Review: How Trump's policies moved stocks »

Catch up on the top…

AMBA

Ambarella

$53.62

1.25 (2.39%)

ON

ON Semiconductor

$18.74

0.67 (3.71%)

AAPL

Apple

$236.21

6.12 (2.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 28

    Oct

  • 30

    Oct

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

, AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

08:48
10/12/19
10/12
08:48
10/12/19
08:48
Periodicals
Bed Bath & Beyond not a bargain, Barron's says »

While Bed Bath &…

BBBY

Bed Bath & Beyond

$12.98

0.89 (7.36%)

AMZN

Amazon.com

$1,730.79

11.115 (0.65%)

TGT

Target

$111.86

1.29 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 21

    Nov

SNE

Sony

$58.16

0.83 (1.45%)

, MSFT

Microsoft

$139.62

0.52 (0.37%)

08:39
10/12/19
10/12
08:39
10/12/19
08:39
Periodicals
Activision, Take-Two to benefit from next videogame cycle, Barron's says »

Sony (SNE) has announced…

SNE

Sony

$58.16

0.83 (1.45%)

MSFT

Microsoft

$139.62

0.52 (0.37%)

ATVI

Activision Blizzard

$54.80

1.1 (2.05%)

TTWO

Take-Two

$122.42

0.02 (0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

  • 23

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 30

    Oct

  • 06

    Nov

  • 07

    Nov

  • 07

    Nov

  • 13

    Nov

  • 21

    Nov

  • 21

    Nov

K

Kellogg

$62.14

-0.27 (-0.43%)

08:27
10/12/19
10/12
08:27
10/12/19
08:27
Periodicals
Kellogg stock looking like worth 'snacking on,' Barron's says »

Kellogg's stock fell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

, ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

08:20
10/12/19
10/12
08:20
10/12/19
08:20
Periodicals
J&J, Pentair among stocks with sage, growing dividends, Barron's says »

Investors seeking yield…

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

ITW

Illinois Tool Works

$154.56

4.68 (3.12%)

NUE

Nucor

$52.69

2.48 (4.94%)

PNR

Pentair

$37.33

1.215 (3.36%)

GWW

Grainger

$305.24

16.49 (5.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 25

    Oct

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

, BAYRY

Bayer

$0.00

(0.00%)

04:55
10/12/19
10/12
04:55
10/12/19
04:55
Conference/Events
Healthcare Made Practical to hold a symposium »

Symposium on Clinical…

ANGO

AngioDynamics

$14.54

0.12 (0.83%)

BAYRY

Bayer

$0.00

(0.00%)

BSX

Boston Scientific

$38.22

0.22 (0.58%)

BTG

B2Gold

$3.25

-0.2 (-5.80%)

JNJ

Johnson & Johnson

$131.35

2.32 (1.80%)

LLY

Eli Lilly

$108.37

1.54 (1.44%)

MDT

Medtronic

$107.61

0.24 (0.22%)

PFE

Pfizer

$36.11

0.31 (0.87%)

PHG

Philips

$42.88

0.99 (2.36%)

TRUMY

Terumo

$0.00

(0.00%)

VAR

Varian Medical

$110.78

1.84 (1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 15

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 29

    Oct

  • 06

    Nov

  • 06

    Nov

  • 13

    Nov

THTX

Theratechnologies

$3.76

0.01 (0.27%)

18:32
10/11/19
10/11
18:32
10/11/19
18:32
Hot Stocks
Theratechnologies: Tesamorelin study results on NAFLD published in Lancet HIV »

Theratechnologies is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WEN

Wendy's

$20.76

0.76 (3.80%)

18:26
10/11/19
10/11
18:26
10/11/19
18:26
Hot Stocks
Wendy's CEO: We are really focused on the long term »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 06

    Nov

  • 13

    Nov

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

, GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

18:25
10/11/19
10/11
18:25
10/11/19
18:25
Periodicals
Breaking Periodicals news story on Alphabet, Alphabet Class A »

DOJ to more closely…

GOOG

Alphabet

$1,213.86

5.88 (0.49%)

GOOGL

Alphabet Class A

$1,214.62

6.18 (0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

BA

Boeing

$374.90

3.97 (1.07%)

18:22
10/11/19
10/11
18:22
10/11/19
18:22
Hot Stocks
Boeing board separates CEO and Chairman roles »

Boeing announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

18:08
10/11/19
10/11
18:08
10/11/19
18:08
Hot Stocks
White House releases letter from China's Xi to President Trump »

The White House posted on…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$296.34

3.1 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.